Captor Therapeutics (WAR:CTX) ROE % Adjusted to Book Value : -10.49% (As of Sep. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Captor Therapeutics ROE % Adjusted to Book Value?

Captor Therapeutics's ROE % for the quarter that ended in Sep. 2024 was -89.26%. Captor Therapeutics's PB Ratio for the quarter that ended in Sep. 2024 was 8.51. Captor Therapeutics's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2024 was -10.49%.

Captor Therapeutics ROE % Adjusted to Book Value Historical Data

The historical data trend for Captor Therapeutics's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Captor Therapeutics ROE % Adjusted to Book Value Chart

Captor Therapeutics Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

-8.84

-4.70

-12.84

Captor Therapeutics Quarterly Data
	Jun19	Dec19	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															-11.45	-12.58	-11.95	-10.16	-10.49

Competitive Comparison of Captor Therapeutics's ROE % Adjusted to Book Value

For the Biotechnology subindustry, Captor Therapeutics's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Captor Therapeutics's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Captor Therapeutics's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Captor Therapeutics's ROE % Adjusted to Book Value falls into.

Captor Therapeutics ROE % Adjusted to Book Value Calculation

Captor Therapeutics's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-85.28%	/	6.64
	=	-12.84%

Captor Therapeutics's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-89.26%	/	8.51
	=	-10.49%

Captor Therapeutics ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Captor Therapeutics's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Captor Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Captor Therapeutics SA (WAR:CTX) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

N/A

Address

ul. Dunska 11, Wroclaw, POL, 54-427

Website

http://www.captortherapeutics.com

Captor Therapeutics SA is a biopharmaceutical company. It is focused on development of protein degradation drugs for cancer and autoimmune diseases, which have limited or no known treatment options.

Captor Therapeutics Headlines

No Headlines